SAR650984
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR650984, covering 2025-05-01 to 2025-05-01. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma [Phase 1]